Literature DB >> 26067859

European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.

Andreas du Bois1, Alexander Reuss, Eric Pujade-Lauraine, Sandro Pignata, Jonathan Ledermann, Antonio Casado, Jalid Sehouli, Mansoor Mirza, Nicoletta Colombo, Christian Marth, Els Witteveen, Jose Del Campo, Paula Calvert, Gerassimos Aravantinos, Mehmet Ali Vardar, Ate G J van der Zee, Jacob Korach, Cagatay Taskiran, Mathias Fehr, Ros Glasspool, Jacobus Pfisterer, David Cibula, Ignace Vergote.   

Abstract

The first version of ENGOT's Requirements for Trials Between Academic Groups and Industry Partners in Europe was published 2010. This first update integrates the experiences made by the ENGOT network and the cooperative group studies while performing, analyzing, and publishing -among others - three large phase III trials. Furthermore, progress in European legislation and its impact on clinical studies in Europe have been considered in this update process.

Mesh:

Year:  2015        PMID: 26067859     DOI: 10.1097/IGC.0000000000000478

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

Authors:  Keiichi Fujiwara; Hiroyuki Fujiwara; Hiroyuki Yoshida; Toyomi Satoh; Kan Yonemori; Shoji Nagao; Takashi Matsumoto; Hiroaki Kobayashi; Hughes Bourgeois; Philipp Harter; Anna Maria Mosconi; Isabel Palacio Vazquez; Alexander Reinthaller; Tomoko Fujita; Philip Rowe; Eric Pujade-Lauraine; Isabelle Ray-Coquard
Journal:  J Gynecol Oncol       Date:  2021-09       Impact factor: 4.401

2.  Current models, challenges and best practices for work conducted between European academic cooperative groups and industry.

Authors:  Rolf A Stahel; Denis Lacombe; Fatima Cardoso; Paolo G Casali; Anastassia Negrouk; Richard Marais; Anita Hiltbrunner; Malvika Vyas
Journal:  ESMO Open       Date:  2020-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.